Nicholas Corcoran's Insider Trades & SAST Disclosures
Nicholas Corcoran's most recent trade in Transmedics Group Inc was a trade of 19,079 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Nicholas Corcoran.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Transmedics Group Inc | Nicholas Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 19,079 | 19,079 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Nicholas Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 12,676 | 33,781 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | Nicholas Corcoran | See Remarks | Sale of securities on an exchange or to another person at price $ 176.02 per share. | 27 Aug 2024 | 10,000 | 21,105 (0%) | 0% | 176.0 | 1,760,200 | Common Stock |
| Transmedics Group Inc | Nicholas Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 7,810 | 11,922 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Nicholas Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.10 per share. | 27 Aug 2024 | 7,810 | 28,915 (0%) | 0% | 66.1 | 516,241 | Common Stock |
| Transmedics Group Inc | Nicholas Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 2,190 | 15,442 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Nicholas Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.14 per share. | 27 Aug 2024 | 2,190 | 31,105 (0%) | 0% | 83.1 | 182,077 | Common Stock |
| Transmedics Group Inc | Nicholas Corcoran | See Remarks | Sale of securities on an exchange or to another person at price $ 129.91 per share. | 06 May 2024 | 3,222 | 21,105 (0%) | 0% | 129.9 | 418,570 | Common Stock |
| Transmedics Group Inc | Corcoran Nicholas | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 17,632 | 17,632 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Corcoran Nicholas | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 11,441 | 24,327 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | Nicholas Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2023 | 19,732 | 19,732 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Nicholas Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2023 | 12,886 | 12,886 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges